ATE1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ATE1 monoclonal antibodies for research focused on understanding arginyltransferase 1 (ATE1) protein function. ATE1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATE1, or arginyltransferase 1, catalyzes post-translational modifications through the addition of arginine residues. This modification process significantly influences protein stability, localization, and function across various cellular processes. ATE1 activity has been linked to multiple cellular signaling pathways and disease mechanisms. Research has shown that ATE1-mediated arginylation affects protein degradation pathways and cellular homeostasis. Understanding ATE1 function continues to reveal new insights into cellular regulation and disease development. Recent studies have highlighted ATE1's role in cardiovascular development and stress response pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of ATE1's biological significance and potential therapeutic applications.